Rasch models to assess the impact of lack of measurement invariance and reveal hidden differences in anxiety and depression between groups and over time in patients with early-stage melanoma or breast cancer using the RespOnse Shift ALgorithm at the

Patient-reported outcome measures (PROMs) are often challenging to analyze and interpret. Indeed, patients may give different answers to PROMs over time, not only because their level of the target construct (e.g. anxiety) has changed but also because their interpretation of the items aiming at measuring the construct has changed. For instance, cancer treatment may trigger changes in the patients’ internal standard of measurement (i.e., recalibration response shift, RS), resulting in a lack of measurement invariance over time. In addition, interpretation of PROMs items may differ according to cancer type (differential item functioning, DIF). If ignored, DIF and RS may impact inferences made from PROMs; they are also crucial to investigate as they may be related to patients’ adaptation after a salient health event, e.g. cancer diagnosis. Our objectives were to show how cross-sectional and longitudinal Rasch models can be used to detect, interpret, and account for DIF and RS, where appropriate, when measuring anxiety and depression in breast cancer and melanoma patients. Anxiety and depression were assessed in breast cancer (n = 337) and melanoma patients (n = 110) using the Hospital Anxiety and Depression Scale (HADS) at 1- (T1) and 6-month (T2) post-diagnosis. DIF and RS analyses were performed using the RespOnse Shift ALgorithm at the Item level (ROSALI) based on Rasch models, i.e. cross-sectional and longitudinal Partial Credit Models (PCM). DIF and RS were identified in the anxiety (DIF and RS) and depression (RS only) subscales of the HADS. DIF and RS had a moderate (anxiety) or significant impact (depression) on the results, providing different conclusions depending on whether or not they were considered. More specifically, wrongly presuming (longitudinal) measurement invariance would have resulted in overestimating the increase in depression over time among breast cancer patients. The ROSALI procedure based on Rasch models is freely available (https://pro-online.net/). ROSALI enabled to investigate measurement invariance at item-level, providing insight into cancer patients’ experience, possibly revealing psychological distress but also psychological adaptation to challenging health events. Although some methods are available, DIF and RS are still too often ignored which can lead biased measurements of constructs and to suboptimal healthcare decision making. n°CT.gov: NCT02893774, registration date: 2016-08-25. Of note, this was a prospective study which was retrospectively registered.

Authors

Institutions

Publication Details

Journal
BMC Medical Research Methodology
Published
2026-01-22
DOI
https://doi.org/10.1186/s12874-025-02756-2
Primary Topic
Cancer survivorship and care
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Rasch models to assess the impact of lack of measurement invariance and reveal hidden differences in anxiety and depression between groups and over time in patients with early-stage melanoma or breast cancer using the RespOnse Shift ALgorithm at the

Marianne Bourdon, Bastien Perrot, Yseulys Dubuy, Myriam Blanchin
BMC Medical Research Methodology
Cancer survivorship and care
article

Rasch models to assess the impact of lack of measurement invariance and reveal hidden differences in anxiety and depression between groups and over time in patients with early-stage melanoma or breast cancer using the RespOnse Shift ALgorithm at the

Marianne Bourdon, Bastien Perrot, Yseulys Dubuy, Myriam Blanchin
article en

Abstract

Patient-reported outcome measures (PROMs) are often challenging to analyze and interpret. Indeed, patients may give different answers to PROMs over time, not only because their level of the target construct (e.g. anxiety) has changed but also because their interpretation of the items aiming at measuring the construct has changed. For instance, cancer treatment may trigger changes in the patients’ internal standard of measurement (i.e., recalibration response shift, RS), resulting in a lack of measurement invariance over time. In addition, interpretation of PROMs items may differ according to cancer type (differential item functioning, DIF). If ignored, DIF and RS may impact inferences made from PROMs; they are also crucial to investigate as they may be related to patients’ adaptation after a salient health event, e.g. cancer diagnosis. Our objectives were to show how cross-sectional and longitudinal Rasch models can be used to detect, interpret, and account for DIF and RS, where appropriate, when measuring anxiety and depression in breast cancer and melanoma patients. Anxiety and depression were assessed in breast cancer (n = 337) and melanoma patients (n = 110) using the Hospital Anxiety and Depression Scale (HADS) at 1- (T1) and 6-month (T2) post-diagnosis. DIF and RS analyses were performed using the RespOnse Shift ALgorithm at the Item level (ROSALI) based on Rasch models, i.e. cross-sectional and longitudinal Partial Credit Models (PCM). DIF and RS were identified in the anxiety (DIF and RS) and depression (RS only) subscales of the HADS. DIF and RS had a moderate (anxiety) or significant impact (depression) on the results, providing different conclusions depending on whether or not they were considered. More specifically, wrongly presuming (longitudinal) measurement invariance would have resulted in overestimating the increase in depression over time among breast cancer patients. The ROSALI procedure based on Rasch models is freely available (https://pro-online.net/). ROSALI enabled to investigate measurement invariance at item-level, providing insight into cancer patients’ experience, possibly revealing psychological distress but also psychological adaptation to challenging health events. Although some methods are available, DIF and RS are still too often ignored which can lead biased measurements of constructs and to suboptimal healthcare decision making. n°CT.gov: NCT02893774, registration date: 2016-08-25. Of note, this was a prospective study which was retrospectively registered.

BMC Medical Research MethodologyVol. 26(1)
Université de Tours (FR), Inserm (FR), Institut de Cancérologie de l'Ouest (FR), Nantes Université (FR)
Openalex Percentile: Top 80%
Cancer survivorship and care
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.